(MAXY) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 22, 2013
(Phil’s Stock World,
9/8/11)
Courtesy of Benzinga. Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced that its Board of Directors has approved an increase to the...(read more)
(Small Cap Copy,
6/21/11)
A little over a year ago in April 2010,
Maxygen, Inc. (MAXY:
Nasdaq)
spun out its Codexis-branded biocatalyst business amid great expectations for getting a better valuation...(read more)
(Penny Stock DD,
3/19/11)
Maxygen (MAXY) shares surged on Thursday amid news that its joint venture interest in Perseid Therapeutics is being acquired by Astellas Pharma for $76 million.
According to their joint...(read more)
Maxygen (MAXY) Company Overview
There is no analysis for MAXY yet. But you can go to Wikinvest to help create one!
